Big pharma faces headwinds in China as vaccine sales decline
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
What's Your Reaction?
